おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Prism Venture Management
company
About
Prism Ventureworks has 5 funds with $1.25 billion in investments. Their most recent fund is for $250M which was raised in June 2005. Each
- 11 - 50
Highlights
Details
- Industries
- Venture Capital
- Founded date
- Jan 1, 1996
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Investor Type
- Venture Capital
Prism Ventureworks has 5 funds with $1.25 billion in investments. Their most recent fund is for $250M which was raised in June 2005.Each of their team members focuses on different industry sectors within technology and life sciences. These industry sectors in technology include the digital living, wireless, mobile and telecommunications markets, as well as promising opportunities in next-generation data centers and on-demand and security applications. In life sciences, we focus on medical devices, therapeutics and breakthrough diagnostics.
Investments
Number of Investments
Number of Lead Investments
5
1
Prism Venture Management has made 5 investments. Their most recent investment was on
May 16, 2014, when Proteon Therapeutics raised $45M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
May 16, 2014
Proteon Therapeutics
|
Series D | $45M | Biotechnology | — |
|
Aug 12, 2011
Proteon Therapeutics
|
Series C | $15.20M | Biotechnology | — |
|
May 28, 2009
Proteon Therapeutics
|
Series B | $50M | Biotechnology | — |
|
Sep 6, 2007
Proteon Therapeutics
|
Series A | $12M | Biotechnology | — |
|
Mar 30, 2006
Proteon Therapeutics
|
Series A | $19M | Biotechnology | Yes |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
